Could a Vitamin-Like drug boost speech in kids with autism?
NCT ID NCT04060017
First seen May 06, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study tests whether a liquid form of leucovorin calcium can improve language and reduce core autism symptoms in young children. Researchers will enroll 80 children aged 2.5 to 5 years with autism and language delays. The treatment lasts about 26 weeks, and the main goal is to measure changes in expressive language ability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Southwestern Autism Research & Resource Center
Phoenix, Arizona, 85016, United States
-
State University of New York, Downstate
Brooklyn, New York, 11203, United States
Conditions
Explore the condition pages connected to this study.